What is the issue price of Senores Pharmaceuticals IPO?

Senores Pharmaceuticals IPO issue price band is ₹372-391 per share with a lot size of 41 Shares.

When is Senores Pharmaceuticals IPO listing date?

Senores Pharmaceuticals IPO listed on Dec 27, 2024 at ₹485.

Senores Pharmaceuticals IPO GMP Today Live ₹78 | Allotment Status & Subscription

Q: How to check Senores Pharmaceuticals IPO allotment status?

You can check Senores Pharmaceuticals IPO allotment status on the registrar (Bigshare Services) website using your PAN or application number.

Q: What is Senores Pharmaceuticals IPO subscription status?

Senores Pharmaceuticals IPO subscription: QIB 44.6x, NII 28.9x, Retail 10.2x.

Live Grey Market Premium+₹78

Expected Listing₹469

Expected Gain+19.95%

Subscription Status

QIB44.6x

NII / HNI28.9x

Retail10.2x

Listing Performance

Issue Price₹372-391

Listing Price₹485

Senores Pharmaceuticals: Detailed Financial Analysis

## Senores Pharmaceuticals IPO: Comprehensive Financial Analysis Senores Pharmaceuticals launched its Initial Public Offering (IPO) with a total issue size of ₹582 Cr, offering shares in the price band of ₹372-391 per share with a minimum lot size of 41 Shares. The IPO opened for subscription on Dec 20, 2024 and closed on Dec 24, 2024. The stock listed at ₹485 against an issue price of ₹372-391, delivering significant listing gains to investors. ### Grey Market Premium (GMP) Analysis The current Grey Market Premium (GMP) for Senores Pharmaceuticals stands at ₹78 per share, indicating positive market sentiment and strong demand in the unofficial grey market. A positive GMP suggests that investors expect the stock to list above its issue price, which is a bullish indicator for potential listing gains. ### Subscription Status The institutional response to Senores Pharmaceuticals IPO has been noteworthy. The Qualified Institutional Buyers (QIB) category was subscribed 44.6x. Non-Institutional Investors (NII) showed 28.9x subscription, while the Retail Individual Investor (RII) category recorded 10.2x subscription. ### Investment Considerations Investors evaluating Senores Pharmaceuticals should consider several key factors. The company operates in a evolving market segment with strong revenue growth trajectory and improving profit margins. The issue price valuation at ₹372-391 per share positions the company at a reasonable valuation compared to listed industry peers. Key risk factors include market volatility, regulatory changes, and sector-specific headwinds that could impact post-listing performance. Investors should carefully review the Draft Red Herring Prospectus (DRHP) filed with SEBI for complete financial disclosures, including revenue trends, profitability metrics, debt-to-equity ratios, and management discussion on future growth strategies. ### Allotment and Listing Timeline The allotment for Senores Pharmaceuticals IPO has been finalized. Investors can check their allotment status through the registrar Bigshare Services's website. The stock is now listed and trading on BSE and NSE. ### Market Outlook Given the strong subscription numbers and positive GMP, Senores Pharmaceuticals appears well-positioned for a favorable listing. The robust institutional demand particularly from QIBs validates the company's business model and growth prospects. However, investors should maintain realistic return expectations and consider holding for medium to long-term value creation rather than purely speculative listing gains. *Disclaimer: Grey Market Premium data is sourced from unofficial market channels and should not be considered investment advice. Past GMP trends do not guarantee future listing performance. Investors should conduct their own due diligence and consult SEBI-registered investment advisors before making investment decisions.*

Frequently Asked Questions

What is Senores Pharmaceuticals IPO GMP today?▼

The current Grey Market Premium for Senores Pharmaceuticals IPO is ₹78. This positive GMP indicates strong market demand.

How to check Senores Pharmaceuticals IPO allotment status?▼

Visit the registrar (Bigshare Services) website and enter your PAN or application number. You can also check on BSE's allotment status page.

What is Senores Pharmaceuticals IPO subscription status?▼

QIB category: 44.6x, NII/HNI category: 28.9x, Retail category: 10.2x.

Should I invest in Senores Pharmaceuticals IPO?▼

Investment decisions should be based on thorough research of the company's financials, growth prospects, and risk factors outlined in the DRHP. Consult a SEBI-registered advisor.

What is the lot size and price band of Senores Pharmaceuticals IPO?▼

The minimum lot size is 41 Shares with a price band of ₹372-391. Total minimum investment required is approximately the lot size multiplied by the upper price band.

Senores Pharmaceuticals IPO

Subscription Status

Listing Performance

Check Senores Pharmaceuticals Allotment Status

Senores Pharmaceuticals: Detailed Financial Analysis

Frequently Asked Questions

Related 2024 IPOs

Tata Technologies

IREDA

Cello World

Mama Earth (Honasa Consumer)

JSW Infrastructure

Mankind Pharma